Common questions about Rubidelle (FAQ)
Q: Aside from contraception, what are the other approved health benefits of Rubidelle?
A: In addition to preventing pregnancy, regulatory documents indicate that Rubidelle is also approved to treat symptoms of Premenstrual Dysphoric Disorder (PMDD). Furthermore, it is indicated for the treatment of moderate acne vulgaris in women who have chosen to use an oral contraceptive for birth control.
Q: Can Rubidelle help with symptoms of acne or skin clarity?
A: Official product information states that this medication is indicated for the treatment of moderate acne vulgaris. This use applies to women who have achieved menarche and who select an oral contraceptive for birth control.
Q: How does Rubidelle specifically affect premenstrual dysphoric disorder (PMDD) symptoms?
A: The medicine is indicated for treating the emotional and physical symptoms of PMDD in women who choose an oral contraceptive for birth control. Clinical trials supporting this use have typically examined symptom relief over about three menstrual cycles.
Q: Does Rubidelle offer any protection against sexually transmitted diseases (STDs)?
A: No, official patient labeling for all combination oral contraceptives clearly states that they do not protect against HIV/AIDS or other sexually transmitted diseases (STDs). Therefore, a barrier method may be necessary for STD prevention.
Q: How long does it typically take for Rubidelle to become fully effective for birth control?
A: If the medication is initiated later than the first day of the menstrual cycle, regulatory documents indicate that the medicine is not effective until after the first 7 consecutive days of administration. Official prescribing information advises the use of a non-hormonal back-up method during the first 7 days.
Q: What should I do if I experience spotting or breakthrough bleeding while taking Rubidelle?
A: If spotting or breakthrough bleeding occurs, the official instruction is that continuation of the regular dosing schedule is typically advised, and interruption of the pill is not necessary. Evaluation by a healthcare professional is necessary if the bleeding persists beyond a few cycles or occurs after regular use.
Q: Is it normal to have changes in my menstrual cycle when starting Rubidelle?
A: Yes, regulatory information lists menstrual irregularities, such as spotting or unscheduled bleeding, as common adverse reactions. These changes are most frequently observed during the first 3 months of use as your body adjusts to the hormones.
Q: What are the most commonly reported side effects when first starting Rubidelle?
A: Based on clinical trial data, the most frequent adverse reactions reported include headache/migraine, menstrual irregularities, nausea/vomiting, and breast pain/tenderness. These effects were reported in 2% or more of the participants.
Q: Can Rubidelle affect my mood or lead to feelings of depression or anxiety?
A: Official regulatory documents list mood changes among the common adverse reactions. These changes can include affect lability (rapid changes in mood) and irritability.
Q: What is the risk of blood clots associated with Rubidelle compared to other birth control options?
A: Official labeling notes that combination oral contraceptives containing Drospirenone may be associated with a higher risk of venous thromboembolism (VTE) than pills containing some other progestins. The risk for blood clots is notably highest during the first year of use of this medication.
Q: How does the drospirenone component in Rubidelle affect potassium levels in the body?
A: The drospirenone component of this medicine possesses anti-mineralocorticoid activity. This anti-mineralocorticoid activity carries a formal risk of additive effects on serum potassium (hyperkalemia), especially when used with other potassium-elevating drugs or in patients with predisposing conditions.
Q: What are the signs or symptoms of a serious, but rare, side effect like a blood clot while on Rubidelle?
A: Serious thromboembolic events, such as a blood clot, can manifest with symptoms like sudden, severe chest pain, shortness of breath, a sudden severe headache, or sudden partial or complete loss of vision. These symptoms are considered serious and require prompt medical attention.
Q: Does Rubidelle interact with common over-the-counter pain relievers like ibuprofen or aspirin?
A: Official regulatory information advises caution when the medicine is used with other potassium-elevating drugs, which includes the long-term or chronic use of certain Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This is due to the potential additive effect on serum potassium levels.
Q: Which prescription medicines are known to reduce the effectiveness of Rubidelle?
A: Medicines that are classified as CYP3A4 enzyme inducers (such as Rifampin and Phenytoin) may reduce the effectiveness of the contraceptive. When taking these medicines, a back-up or alternative method of contraception is necessary for 28 days following their use, according to regulatory guidelines.
Q: Can taking certain antibiotics interfere with how well Rubidelle works?
A: Regulatory documents identify the antibiotic Rifampin as an inducer of an enzyme that may reduce contraceptive effectiveness. General warning language often advises patients to check with a healthcare professional regarding other classes of antibiotics to confirm if any backup contraception is needed.
Q: Is it safe to consume alcohol while taking Rubidelle?
A: The official drug label does not typically list a specific interaction between the medication and alcohol. Maintaining pill consistency, which is essential for effectiveness, is important during use.
Q: Are there any food or drinks, like grapefruit juice, that should be avoided while using Rubidelle?
A: Yes, official drug interaction databases advise that grapefruit and grapefruit juice may increase the blood levels of certain hormones in the medicine. It is generally advised to limit consumption of grapefruit and grapefruit juice due to this potential effect.
Q: Does Rubidelle interfere with the results of any routine lab or blood tests?
A: Official labeling notes that the use of oral contraceptives may affect the results of certain laboratory tests. These can include tests for coagulation factors, lipids (fats), glucose tolerance, and binding proteins in the blood.
Q: Can Rubidelle be used by individuals who have been diagnosed with high blood pressure or diabetes?
A: This medication is contraindicated (should not be used) in women with uncontrolled hypertension (high blood pressure). It is also contraindicated in women with diabetes mellitus that has resulted in damage to blood vessels, eyes, nerves, or kidneys.
Q: How long after stopping Rubidelle can a person expect to get pregnant?
A: The return of fertility is generally expected shortly after discontinuing the combination hormonal contraceptive. However, if you had irregular periods before starting the pill, those irregularities may return after stopping the medication.
Q: Does Rubidelle affect long-term fertility or the ability to conceive in the future?
A: There is no information in the current regulatory labeling that states oral contraceptives cause long-term infertility. Fertility is generally expected to return to your baseline once the medication is stopped.
Q: Why are the tablets in the Rubidelle pack different colors, and what do they mean?
A: The different colors indicate the type of tablet you are taking. The active pills contain the hormones (Drospirenone and Ethinyl Estradiol), while the other color tablets are inert or reminder pills that contain no active hormones. They serve to keep you on schedule.
Q: What is the significance of the folate component found in certain versions of Rubidelle?
A: Certain versions of this medicine include a folate (levomefolate calcium) component. The inclusion of folate is indicated for the purpose of increasing folate levels in women who choose an oral contraceptive, with the aim of reducing the risk of neural tube defects in a pregnancy conceived during or shortly after stopping the medication.
Q: What steps are taken to minimize the risk of high potassium levels (hyperkalemia) when prescribing Rubidelle?
A: Official prescribing information requires specific measures for high-risk patients due to the drospirenone component. For patients taking potassium-elevating medications, serum potassium levels must be checked during the first month of treatment to monitor for hyperkalemia.
Q: How does Rubidelle affect a person's libido or sex drive?
A: Official regulatory documents list decreased libido (sex drive) as one of the potential adverse reactions reported in clinical trials for this combination of hormones. This adverse reaction is noted as one of the potential effects of hormonal change.
Q: Does Rubidelle change the timing or flow of my period after the initial adjustment phase?
A: The medication is designed to regulate the cycle by creating a scheduled withdrawal bleed. While irregular bleeding is possible initially, if you continue to experience changes in the timing or flow after the first few months, a healthcare professional may need to be consulted to rule out other factors.
Q: Are there generic versions of Rubidelle available, and are they equally effective?
A: Generic versions of the active ingredient combination (drospirenone and ethinyl estradiol) are available on the market. These generic products are reviewed by the FDA to be bioequivalent to the brand-name product.
Q: Can stomach issues like nausea or vomiting be lessened by taking Rubidelle with food?
A: The official instructions state the tablet can be taken with or without food. Regulatory documents note that taking the pill after the evening meal or at bedtime may be preferred, which could potentially help minimize any gastrointestinal discomfort.
Q: What should I know about the safety of Rubidelle if I am breastfeeding or recently gave birth?
A: Official labeling advises that use is not recommended while breastfeeding because combination oral contraceptives may reduce milk production. For women who are not breastfeeding, initiation should be no earlier than four weeks after delivery due to an elevated risk of blood clots postpartum.
Q: Does Rubidelle affect bone mineral density over time?
A: Official regulatory documents state that it is currently unknown whether the medication may cause a clinically relevant loss of bone mineral density. The patient labeling mentions the potential for bone loss.
Q: Is there a link between long-term use of Rubidelle and an increased risk of any cancers?
A: Official safety information reports a reduced risk for endometrial and ovarian cancers associated with oral contraceptive use. However, some studies have noted a slight increased risk of breast and cervical cancers, which tends to decrease after stopping the medication.
Q: Why do some people experience a decreased interest in sex while using Rubidelle?
A: Decreased libido (sex drive) is listed as an adverse reaction in the clinical trial data for this combination of hormones. The reason for this side effect is related to the hormonal changes that the medicine causes.
Q: What are the known effects of Rubidelle on cholesterol and triglyceride levels?
A: Official information indicates that combination hormonal contraceptives may adversely affect lipid levels, including increasing serum triglycerides. Patients with hypertriglyceridemia should be monitored due to the risk of pancreatitis.
Q: Is the tiredness or fatigue experienced while taking Rubidelle a common side effect?
A: Yes, fatigue (unusual tiredness or weakness) is listed as an adverse reaction reported in clinical trials for this medicine. It is classified as a common effect, particularly noted in studies for PMDD treatment.
Q: If I am switching from another oral contraceptive, when should I start taking Rubidelle?
A: If you are switching from another combined oral contraceptive, official instructions state that the first active tablet of Rubidelle should be taken on the day the new pack of your previous pill would have typically started.
Q: What are the signs of an allergic reaction to the ingredients in Rubidelle?
A: Although rare, severe hypersensitivity reactions are possible. Symptoms listed in regulatory documents include anaphylactic reactions and angioedema, which involves swelling of the face, lips, mouth, tongue, or throat. These types of severe reactions require immediate medical attention.
